Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Agios Pharmaceuticals at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Agios Pharmaceuticals brings 3 presentations to ASH 2026 in New Orleans, and exhibits at Booth 929. Its program centres on sickle cell disease and thalassemia. It presents sessions on an oral thalassemia treatment and on hemolysis in sickle cell disease, and supports a symposium on sickle cell therapies.

OrganizationASH 2026 Attendance
Biotech
Commercial-stage biopharmaceutical company with roots in hematology, developing medicines for rare diseases.
Booth
Exhibiting at Booth 929
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
7:00am–10:00am
A Hematologist’s Guide to the Sickle Cell Disease Revolution: Genes, Activators, and Beyond
Approved and emerging gene therapies and new pyruvate kinase activators for sickle cell disease, and how to match patients to each and refer them.
Red cells · Cell & gene

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Agios Pharmaceuticals

Tell us what you sell and we’ll find the people at Agios Pharmaceuticals most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction